Guillain-Barré Syndrome in Chile: Incidence and Mortality (2013-2019).

IF 4 3区医学 Q2 CLINICAL NEUROLOGY

Neuroepidemiology Pub Date : 2025-07-10 DOI:10.1159/000547305

Juan Francisco Idiáquez, Rodrigo Salinas, Gabriel Cea

{"title":"Guillain-Barré Syndrome in Chile: Incidence and Mortality (2013-2019).","authors":"Juan Francisco Idiáquez, Rodrigo Salinas, Gabriel Cea","doi":"10.1159/000547305","DOIUrl":null,"url":null,"abstract":"Introduction: Guillain-Barré syndrome (GBS) is a rare autoimmune disorder of the peripheral nervous system with incidence rates varying across regions. Based on hospital discharge data, this study aimed to analyze the incidence and mortality of GBS in Chile between 2013 and 2019.Methods: A retrospective review of GBS cases, identified using the ICD-10 code G61.0, was conducted using national hospital discharge records. The incidence rates were calculated annually and adjusted for the population. Demographic and clinical variables, including sex, age, insurance type, and outcomes, were analyzed.Results: A total of 1,696 cases were identified, yielding an annual incidence rate of 1.46 per 100,000 (95% CI: 1.28-2.64). Most cases occurred in males (58.8%), with a mean age of 46.62 years. The mortality rate was 1.7%, and the high survival rate was 98.3%.Conclusion: The incidence of GBS in Chile is comparable to the global rates, with a slight male predominance and a high survival rate. Further studies are warranted to explore the potential rurality and climatic factors influencing GBS incidence in Chile.","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-7"},"PeriodicalIF":4.0000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503500/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroepidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000547305","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Guillain-Barré syndrome (GBS) is a rare autoimmune disorder of the peripheral nervous system with incidence rates varying across regions. Based on hospital discharge data, this study aimed to analyze the incidence and mortality of GBS in Chile between 2013 and 2019.

Methods: A retrospective review of GBS cases, identified using the ICD-10 code G61.0, was conducted using national hospital discharge records. The incidence rates were calculated annually and adjusted for the population. Demographic and clinical variables, including sex, age, insurance type, and outcomes, were analyzed.

Results: A total of 1,696 cases were identified, yielding an annual incidence rate of 1.46 per 100,000 (95% CI: 1.28-2.64). Most cases occurred in males (58.8%), with a mean age of 46.62 years. The mortality rate was 1.7%, and the high survival rate was 98.3%.

Conclusion: The incidence of GBS in Chile is comparable to the global rates, with a slight male predominance and a high survival rate. Further studies are warranted to explore the potential rurality and climatic factors influencing GBS incidence in Chile.

查看原文本刊更多论文

智利吉兰-巴罗综合征发病率和死亡率（2013-2019年）。

格林-巴罗综合征（GBS）是一种罕见的周围神经系统自身免疫性疾病，不同地区的发病率不同。基于出院数据，本研究旨在分析智利2013 - 2019年GBS的发病率和死亡率。方法：回顾性分析使用ICD-10代码G61.0识别的GBS病例，使用国家医院出院记录。发病率每年计算一次，并根据人群进行调整。分析了人口统计学和临床变量，包括性别、年龄、保险类型和结果。结果：共发现1696例，年发病率为1.46 / 10万（95% CI 1.28-2.64）。以男性居多（58.8%），平均年龄46.62岁。死亡率为1.7%，高生存率为98.3%。结论：智利GBS发病率与全球相当，男性略占优势，生存率较高。有必要进一步研究影响智利GBS发病率的潜在乡村和气候因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neuroepidemiology 医学-公共卫生、环境卫生与职业卫生

CiteScore

9.90

自引率

1.80%

发文量

审稿时长

6-12 weeks

期刊介绍： ''Neuroepidemiology'' is the only internationally recognised peer-reviewed periodical devoted to descriptive, analytical and experimental studies in the epidemiology of neurologic disease. The scope of the journal expands the boundaries of traditional clinical neurology by providing new insights regarding the etiology, determinants, distribution, management and prevention of diseases of the nervous system.